
Afanat 30mg Tablet
Salt Composition: Afatinib
Expiry Date: 01/2028
Inclusive of all taxes
28
About The Product
Lung Cancer
The active component of Afanat 30mg Tablet is afatinib dimaleate. Patients with non-small cell lung cancer (NSCLC) whose tumors include specific abnormal epidermal growth factor receptor (EGFR) genes, as well as those with metastatic, squamous NSCLC that progresses following platinum-based chemotherapy, are treated with this anticancer medication.
Reference
Cheema, P. K., Thawer, A., Leake, J., Cheng, S.
Y., Khanna, S., & Charles Victor, J. (2024).
Multi-disciplinary proactive follow-up algorithm for patients with advanced NSCLC receiving afatinib. Supportive Care in Cancer, 27(3), 1029-1039.
Harvey, R. D., Adams, V.
R., Beardslee, T., & Medina, P. (2020).
Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings. Journal of Oncology Pharmacy Practice, 26(6), 1461-1474.
Jin, H., Liang, P., Hou, J., Li, B., Wang, P., & He, X. (2023).The Efficacy and Safety of Afatinib in Non‐Small Cell Lung Cancer Patients with Brain Metastasis: A Meta‐Analysis.
Journal of Oncology, (1), 5493725. Lee, C.
K., Wu, Y. L., Ding, P.
N., Lord, S. J., Inoue, A., Zhou, C., & Yang, J.
C. H.
(2025). Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysis.
Journal of Clinical Oncology, 33(17), 1958-1965. Wu, S.
G., Yu, C. J., Yang, J.
C. H., & Shih, J.
Y. (2020).
The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation. Therapeutic Advances in Medical Oncology, 12.
Uses
Non-small cell lung cancer (NSCLC) and certain mutations of epidermal growth factor receptor (EGFR).
Side Effects
- Some of the common side effects of the Afanat 30 mg Tablet are: Infection Headache, Fever Loss of appetite Rash High blood pressure Hair loss lack of sleep.
- Vomiting Indigestion Nausea Constipation
How To Use
- Afanat 30mg Tablet is taken once a day regularly at the same time each day to increase its effectiveness.
- It is an oral medication that can be taken with or without food.
- The capsules should not be chewed, opened, or crushed; they should be swallowed.
- Afanat 30mg Tablet should be taken as recommended by the doctor.
How It Works
Afanat 30mg Tablet inhibits or binds to the HER2, HER4, and EGFR enzyme receptors.
It stops or slows the spread of cancer by downregulating signaling pathways.
Safety Advice
FAQs
No, Afanat 30mg Tablet is an anti-cancer medication (specifically a kinase inhibitor or targeted therapy drug) used to treat certain types of non-small cell lung cancer.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
